BRIEF published on 01/19/2026 at 10:05, 3 months 20 days ago Medios AG entre sur le marché du cannabis médicinal Marché Européen Medios AG Distribution Pharmaceutique Cannabis Médicinal Partenariat Bedrocan
PRESS RELEASE published on 01/19/2026 at 10:00, 3 months 20 days ago Medios AG enters market for medicinal cannabis Medios AG expands into medicinal cannabis market with exclusive distribution rights for Bedrocan products in Europe, strengthening expertise in oncology and neurology Pharmaceuticals Oncology Medios AG Medicinal Cannabis Bedrocan
BRIEF published on 11/11/2025 at 07:29, 5 months 27 days ago Medios AG annonce une forte croissance de ses bénéfices début 2025 EBITDA Performance Financière Medios AG Croissance Des Revenus Médicaments
BRIEF published on 11/11/2025 at 07:29, 5 months 27 days ago Medios AG Reports Robust Earnings Growth in Early 2025 EBITDA Revenue Growth Financial Performance Pharmaceuticals Medios AG
PRESS RELEASE published on 11/11/2025 at 07:24, 5 months 27 days ago Medios AG achieves strong growth in earnings and profit margin in the first nine months of 2025 Medios AG achieves 9.2% revenue growth and 26.1% increase in EBITDA pre1 in the first nine months of 2025. New CEO appointed. Outlook confirmed. Details in press release EBITDA Revenue Growth CEO Appointment Medios AG 2025 Outlook
BRIEF published on 11/03/2025 at 10:02, 6 months 5 days ago Thomas Meier nommé PDG de Medios AG Stratégie De Croissance Medios AG Nomination Du PDG Pharmacie Spécialisée Thomas Meier
BRIEF published on 11/03/2025 at 10:02, 6 months 5 days ago Thomas Meier Appointed CEO of Medios AG Growth Strategy CEO Appointment Medios AG Specialty Pharma Thomas Meier
PRESS RELEASE published on 11/03/2025 at 09:57, 6 months 5 days ago Thomas Meier becomes new CEO of Medios AG Thomas Meier appointed as new CEO of Medios AG effective February 1, 2026, succeeding Matthias Gaertner. Meier's past roles include CEO of Bachem Holding AG. Medios AG aims for further growth under his leadership CEO Appointment Medios AG Specialty Pharma Thomas Meier Bachem Holding AG
BRIEF published on 10/24/2025 at 11:09, 6 months 15 days ago Medios AG : Réattribution des actions Bencis Medios AG Pharmaceutique Spécialisée Réallocation Des Actions Bencis Capital Partners Groupe Janus Henderson
BRIEF published on 10/24/2025 at 11:09, 6 months 15 days ago Medios AG: Reallocation of Bencis Shares Medios AG Specialty Pharma Share Reallocation Bencis Capital Partners Janus Henderson Group
Published on 05/09/2026 at 01:30, 2 hours 17 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 3 hours 47 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 7 hours 9 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 8 hours 34 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 8 hours 45 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 8 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 8 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 8 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 8 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 8 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
